OXOLIFE
Barcelona, Spain· Est.
OXOLIFE is developing a drug in a specific field were none has been effective to date, acting directly on the endometrium enhancing embryo implantation and increasing Live Birth Rates
Private Company
Total funding raised: $9.2M
About
OXOLIFE is developing a drug in a specific field were none has been effective to date, acting directly on the endometrium enhancing embryo implantation and increasing Live Birth Rates
Small Molecules
Funding History
2Total raised:$9.2M
Series A$8M
Seed$1.2M